Gliomas following organ transplantation: analysis of the contents of a tumor registrySCHIFF, David.Journal of neurosurgery. 2004, Vol 101, Num 6, pp 932-934, issn 0022-3085, 3 p.Article

Can APOE genotyping predict cognitive damage from brain tumor therapy?SCHIFF, David.Neurology. 2014, Vol 83, Num 4, issn 0028-3878, p. 326Article

Adrenal insufficiency secondary to glucocorticoid withdrawal in patients with brain tumorNEVES DA SILVA, Amaldo; SCHIFF, David.Surgical neurology. 2007, Vol 67, Num 5, pp 508-510, issn 0090-3019, 3 p.Article

Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group reportGRISARIU, Sigal; AVNI, Batia; SHALOM, Edna et al.Blood. 2010, Vol 115, Num 24, pp 5005-5011, issn 0006-4971, 7 p.Article

Bevacizumab Alone and in Combination With Irinotecan in Recurrent GlioblastomaFRIEDMAN, Henry S; PRADOS, Michael D; VREDENBURGH, James et al.Journal of clinical oncology. 2009, Vol 27, Num 28, pp 4733-4740, issn 0732-183X, 8 p.Article

Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphomaSHAH, Gaurav D; YAHALOM, Joachim; CORREA, Denise D et al.Journal of clinical oncology. 2007, Vol 25, Num 30, pp 4730-4735, issn 0732-183X, 6 p.Article

Central nervous system toxicity from cancer therapiesSCHIFF, David; WEN, Patrick.Hematology/oncology clinics of North America. 2006, Vol 20, Num 6, issn 0889-8588, x, 1377-1398 [23 p.]Article

Clinical implications of status epilepticus in patients with neoplasmsCAVALIERE, Robert; FARACE, Elana; SCHIFF, David et al.Archives of neurology (Chicago). 2006, Vol 63, Num 12, pp 1746-1749, issn 0003-9942, 4 p.Article

Paraneoplastic recurrent multifocal encephalitis presenting with epilepsia partialis continuaMUT, Melike; SCHIFF, David; DALMAU, Josep et al.Journal of neuro-oncology. 2005, Vol 72, Num 1, pp 63-66, issn 0167-594X, 4 p.Article

Anti-GAD antibody positive stiff-limb syndrome in multiple myelomaSCHIFF, David; DALMAU, Josep; MYERS, Delynne J et al.Journal of neuro-oncology. 2003, Vol 65, Num 2, pp 173-175, issn 0167-594X, 3 p.Article

Spinal cord compressionSCHIFF, David.Neurologic clinics. 2003, Vol 21, Num 1, issn 0733-8619, viii, 67-86 [21 p.]Article

A Randomized Trial of Bevacizumab for Newly Diagnosed GlioblastomaGILBERT, Mark R; DIGNAM, James J; JERAJ, Robert et al.The New England journal of medicine. 2014, Vol 370, Num 8, pp 699-708, issn 0028-4793, 10 p.Article

Bone health in patients with brain tumors. CommentaryNEVES DA SILVA, Arnaldo; HERAS-HERZIG, Ailleen; SCHIFF, David et al.Surgical neurology. 2007, Vol 68, Num 5, pp 525-533, issn 0090-3019, 9 p.Article

Pharmacokinetic and Tumor Distribution Characteristics of Temsirolimus in Patients with Recurrent Malignant GliomaKUHN, John G; CHANG, Susan M; DEANGELIS, Lisa et al.Clinical cancer research. 2007, Vol 13, Num 24, pp 7401-7406, issn 1078-0432, 6 p.Article

Medical management of patients with brain tumorsWEN, Patrick Y; SCHIFF, David; KESARI, Santosh et al.Journal of neuro-oncology. 2006, Vol 80, Num 3, pp 313-332, issn 0167-594X, 20 p.Article

Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs : A North American brain tumor consortium studyCLOUGHESY, Timothy F; KUHN, John; DEANGELIS, Lisa et al.Journal of clinical oncology. 2005, Vol 23, Num 27, pp 6647-6656, issn 0732-183X, 10 p.Conference Paper

Outcome in adult low-grade glioma : The impact of prognostic factors and treatmentSCHIFF, David; BROWN, Paul D; GIANNINI, Caterina et al.Neurology. 2007, Vol 69, Num 13, pp 1366-1373, issn 0028-3878, 8 p.Article

LMO2 and BCL6 are associated with improved survival in primary central nervous system lymphomaLOSSOS, Chen; BAYRAKTAR, Soley; ABREY, Lauren et al.British journal of haematology. 2014, Vol 165, Num 5, pp 640-648, issn 0007-1048, 9 p.Article

NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modalitySTUPP, Roger; WONG, EricT; RAM, Zvi et al.European journal of cancer (1990). 2012, Vol 48, Num 14, pp 2192-2202, issn 0959-8049, 11 p.Article

PHASE I STUDY OF VANDETANIB WITH RADIOTHERAPY AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMADRAPPATZ, Jan; NORDEN, Andrew D; SCHIFF, David et al.International journal of radiation oncology, biology, physics. 2010, Vol 78, Num 1, pp 85-90, issn 0360-3016, 6 p.Article

Functional and molecular interactions between the HGF/c-Met pathway and c-Myc in large-cell medulloblastomaYUNQING LI; GUESSOUS, Fadila; ABOUNADER, Roger et al.Laboratory investigation. 2008, Vol 88, Num 2, pp 98-111, issn 0023-6837, 14 p.Article

Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma MultiformeREARDON, David A; FINK, Karen L; SCHIFF, David et al.Journal of clinical oncology. 2008, Vol 26, Num 34, pp 5610-5617, issn 0732-183X, 8 p.Article

Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs : A north american brain tumor consortium studyCLOUGHESY, Timothy F; WEN, Patrick Y; LIEBERMAN, Frank et al.Journal of clinical oncology. 2006, Vol 24, Num 22, pp 3651-3656, issn 0732-183X, 6 p.Article

Neurologic complications of solid tumorsWEN, Patrick Y; SCHIFF, David.Neurologic clinics. 2003, Vol 21, Num 1, issn 0733-8619, viii, 107-140 [35 p.]Article

Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term OutcomeMORRIS, Patrick G; CORREA, Denise D; KARIMI, Sasan et al.Journal of clinical oncology. 2013, Vol 31, Num 31, pp 3971-3979, issn 0732-183X, 9 p.Article